ITI News Archive
Stanford Medicine News
Progress in peanut-allergy immunotherapy
As immunotherapy for peanut allergy advances, a Stanford allergy expert discusses what that means for parents, providers and the future of allergy treatments.
Farming linked to gut microbiome changes
Researchers at Stanford and several other institutions have linked the gut ecosystems of four Himalayan groups to the extent of each group’s departure from a hunter-gatherer lifestyle.
The basics of acute flaccid myelitis
Small clusters of cases of infectious paralysis are occurring in young children across North America. A Stanford pediatric neurologist is working to understand the disease.
Heart recipient who gave birth looks back
Just 28 when she received a new heart at Stanford Hospital in 1991, Yolanda Ishaq went on to become the first heart transplant recipient to have a child at Stanford.
Bloodstream pathogens often come from gut
A computational tool designed by Stanford scientists makes it easier to identify the source of bloodstream infections and, ideally, rid patients of reservoirs where potentially troublesome microbes reside.
Decision scientist seeks hepatitis B solutions
Mehlika Toy merged her interests in infectious diseases and mathematics to forge a career in decision science. She builds models to estimate the impact of clinical interventions to inform health policy.
Safer gene therapy?
A new study gives Stanford researchers hope that they may have solved a big problem plaguing gene therapy: the prospect of an autoimmune attack.
Technique for quickly spotting TB
A newly created two-piece fluorescent probe gets activated when it comes in contact with tuberculosis bacteria in a phlegm.
Gut molecule protects against Salmonella
A molecule called propionate inhibits the growth of Salmonella in mice and may be a promising new treatment for people sickened by the pathogen, according to a new Stanford study.
Team seeks to decipher vulnerability to virus
Stanford researchers have joined forces to learn how immune cells in some kidney transplant patients fight a common virus. The work could lead to a test to predict who is at risk, and possibly develop new treatments.